Pfizer (PFE) technical indicators: RSI, moving averages, 52-week range
Pfizer (PFE) closed at 30.11 USD on 2026-10-20, up 2.28%, the 85th percentile of its daily moves by size since 1972. It is 0.46% below its 52-week high and 27.48% above its 52-week low, and is above its 20-, 50- and 200-day moving averages. Its 20-day return of +7.81% is in the 86th percentile of its history since 1972. Pfizer (PFE) had an RSI(14) of 72.56 at the 2026-10-20 close, in the 97th percentile of its history since 1972. At the 2026-10-20 close, the 52-week high of Pfizer (PFE) was 30.25 USD, set on 2026-10-20, and the 52-week low 23.62 USD, set on 2026-07-06. At the 2026-10-20 close, the 20-day moving average of Pfizer (PFE) was 28.54 USD. At the 2026-10-20 close, the 50-day moving average of Pfizer (PFE) was 28.08 USD. At the 2026-10-20 close, the 200-day moving average of Pfizer (PFE) was 26.61 USD.
Day’s range 29.59–30.25 USD · closed 78.8% of range · width 1.17× ATR52-week low 23.62 (2026-07-06) · high 30.25 (2026-10-20)97.9% of the way from low to high
Today (changed)
New 52wk intraday high (30.25) — exceeded the prior 52wk high of 29.88 by 1.24%; RSI 72.6 — crossed above 70 (overbought boundary); Volatility: Low → Normal (20-day volatility 23rd → 29th pctile)
RSI 72.6 — crossed above 70 (overbought boundary): previous same-direction cross 2026-09-02, 33 sessions earlier.
3 state changes · 0 notable moves
Shifts since 2026-10-19 — two standing rows, then the most unusual shifts against each metric’s own history
| Metric | Prior | Today | Change | Δ vs 2026-10-13 | Move percentile |
|---|---|---|---|---|---|
| RVOL 1.14× | 20th | 72nd | +52 pctile pts | — | — |
| MACD histogram | +0.14 | +0.17 | +0.03 | — | — |
| 200-day MA dist | +10.73% | +13.15% | +2.42 pp | +6.09 pp | 86th |
| RSI | 66.91 | 72.56 | +5.65 pts | +15.71 pts | 80th |
The first two rows are always shown and are not ranked; — marks a cell that does not apply.
Follow these changes: RSS feed
Opened up 0.78% from the prior close; closed in the upper quarter of the day's range, above the prior close.
- ≥2% move today
- 52-week high today
- 53 sessions above 200-day MA
- FOMC in 8d
- Earnings in 14d
- Jobs report in 17d
Unusualness #12/73 (1 = most unusual) (was #27). Its most notable reading: 97.9% of its 52-week range.
Standing distances: RSI 72.56 is 2.56 pts above 70 · price 0.46% (0.3× ATR) below the 52-week high · 27.48% (11.6× ATR) above the 52-week low · 5.52% (2.8× ATR) above the 20-day MA (28.54) · 7.21% (3.6× ATR) above the 50-day MA (28.08) · 13.15% (6.2× ATR) above the 200-day MA (26.61)
Technical assessment
A transparent, rules-based reading of the statistics on this page — informational and educational only, not investment advice or a recommendation to buy or sell. Each scored factor shows the metrics behind it; full numbers are in the sections below.
Factor tally: 4 positive
| Factor | Reading | Summary |
|---|---|---|
| Short-term momentum | 5/10-day returns: +6.13% · +9.49%; MACD +0.47 above signal +0.30; histogram +0.17 (up 0.03 on the previous session). | Improving |
| Medium-term trend | 20/60/120-day returns: +7.81% · +22.05% · +14.66%. | Positive |
| Moving averages | price vs 20/50/200-day MA: +5.52% · +7.21% · +13.15%; stack 20d > 50d > 200d. | Above trend MAs |
| Relative performance | vs the S&P 500 over 20/60/252 days: +8.48% · +18.01% · +7.11%; vs the Nasdaq 100: +11.80% · +16.85% · +4.02%. | Outperforming |
Figures reflect the official regular-session close for 2026-10-20.
Price chart
Price and momentum
- Close
- 30.11 USD
- Daily change
- up 2.28% — 85th percentile by magnitude since 1972 (13560 obs)
- vs market (same day)
- S&P 500 +0.28% · Nasdaq 100 -0.10%
- MACD (12, 26, 9)
- +0.47 (above signal) · signal +0.30 · histogram +0.17 · +0.03 vs 2026-10-19
- 20-day return
- +7.81% — 86th percentile since 1972 (13541 obs) · +6 pctile pts vs 2026-10-19
RSI(14)
- RSI(14)
- 72.56 — 97th percentile since 1972 (13547 obs) · +5.65 (80th percentile move · +6 pctile pts) vs 2026-10-19 · +15.71 vs 2026-10-13
- RSI last overbought
- today (2026-10-20)
- RSI last oversold
- 118 days ago (2026-06-24)
Session
- Listing
- Exchange: NYSE, Currency: USD
- Open
- 29.67 USD
- High
- 30.25 USD
- Low
- 29.59 USD
- Prior close
- 29.44 USD
- Prior O/H/L
- O 29.31 USD · H 29.69 USD · L 29.25 USD
- Gap (overnight)
- +0.78% — 80th percentile by magnitude since 1972 (13560 obs)
- Intraday (session)
- +1.48%
- Intraday range
- 2.19% of price — 62nd percentile since 1972 (13561 obs)
- Close position
- 78.8% of range
- Up days (history)
- 49.9% of 12251 directional sessions (flat days excluded)
- Daily-move distribution
- -2.63% / -0.93% / +0.00% / +0.99% / +2.90% (p5–p95; -0.79 to +0.87 USD at today’s close; 13560 obs)
- ≥4% daily moves
- 0 of last 20 sessions (0%)
Moving averages
| Period | Value | Price vs MA |
|---|---|---|
| 20-day MA | 28.54 USD | +5.52% · +1.95 pp (80th percentile move since 1972) vs 2026-10-19 · +4.44 pp vs 2026-10-13 · 2.8× its typical daily range (ATR) |
| 50-day MA | 28.08 USD | +7.21% · +2.15 pp (84th percentile move since 1972) vs 2026-10-19 · +4.99 pp vs 2026-10-13 · 3.6× its typical daily range (ATR) |
| 200-day MA | 26.61 USD | +13.15% · +2.42 pp (86th percentile move since 1972) vs 2026-10-19 · +6.09 pp vs 2026-10-13 · 6.2× its typical daily range (ATR) |
| VWAP (20-day) | 28.53 USD | +5.55% |
| VWAP (60-day) | 27.55 USD | +9.31% |
Moving-average trend & crossovers
- 200-day slope (20-session)
- +1.20% · rising
- Price vs 20-day MA
- closed above it for 8 sessions, since 2026-10-09
- Price vs 50-day MA
- closed above it for 55 sessions, since 2026-08-04
- Price vs 200-day MA
- closed above it for 53 sessions, since 2026-08-06
- 20-day / 50-day
- 20-day crossed above 50-day · 2026-08-07 (74 days ago)
- 20-day / 200-day
- 20-day crossed above 200-day · 2026-08-19 (62 days ago)
- 50-day / 200-day
- 50-day crossed above 200-day · 2026-09-11 (39 days ago)
52-week range (changed)
- Position
- 97.9% of range
- Drawdown from all-time intraday high
- -51.21% · 1765 days ago (2021-12-20)
- Maximum drawdown (10-year, close-basis)
- -64.75% · 2021-12-16 61.25 USD → 2025-04-10 21.59 USD · not yet recovered
- 52-week high
- 30.25 USD · price -0.46% · 2026-10-20 (today)
- 52-week low
- 23.62 USD · price +27.48% · 2026-07-06 (106 days ago)
- Fresh 52-week extremes, last 20 sessions
- 3 new highs
Volatility (changed)
- 5-day realised volatility
- 1.392% daily · 22.1% annualised — 52nd percentile since 1972 (13556 obs)
- 20-day realised volatility
- 1.189% daily · 18.9% annualised — 29th percentile since 1972 (13541 obs) · +6 pctile pts vs 2026-10-19 · +0.29 pp vs 2026-10-13
- 60-day realised volatility
- 1.239% daily · 19.7% annualised — 23rd percentile since 1972 (13501 obs)
- 120-day realised volatility
- 1.276% daily · 20.3% annualised — 23rd percentile since 1972 (13441 obs)
- Term structure (20d vs 120d)
- 0.93× — 1.189% vs 1.276% (near-term in line with its longer-horizon baseline)
- ATR (14)
- 0.56 USD · 1.87% of price — 29th percentile since 1972 (13547 obs)
Volume and participation
- Relative volume
- 1.14× prior 20-day average (excl. today) — 72nd percentile since 1972 (13541 obs) · +52 pctile pts vs 2026-10-19 · +0.32× vs 2026-10-13
- Volume
- 34.4M shares
- 3-month avg volume (63 sessions)
- 34.8M shares/day
- Dollar volume
- $1.04B — 50th percentile (trailing 252 sessions) · 85th percentile (trailing 20 sessions) · scales with price level; see relative volume above for a price-neutral read
- 20-day avg $ volume
- $872M
Short interest and short volume
- Short volume
- 36.4% of reported volume (5.05M of 13.9M shares; FINRA off-exchange/TRF volume, not the consolidated tape, as of 2026-10-20) · prior 20-session average 46.3% · 16th percentile of the past 252 sessions
- Days to cover
- 4.41 · short interest 150M shares ÷ 34M avg daily volume (settlement-window average), -3.2% since prior settlement (FINRA, settled 2026-09-30; reported twice monthly)
- Short interest (% of shares outstanding)
- 2.64% of shares outstanding (not free float) — short interest settled 2026-09-30 ÷ shares outstanding cover-page as-of 2026-07-29
Returns
- 5-day
- +6.13% — 95th percentile since 1972 (13556 obs) · from 28.37 USD on 2026-10-13
- 10-day
- +9.49% — 96th percentile since 1972 (13551 obs) · from 27.50 USD on 2026-10-06
- 20-day
- +7.81% — 86th percentile since 1972 (13541 obs) · from 27.93 USD on 2026-09-22
- 60-day
- +22.05% — 96th percentile since 1972 (13501 obs) · from 24.67 USD on 2026-07-27
- 120-day
- +14.66% — 76th percentile since 1972 (13441 obs) · from 26.26 USD on 2026-04-29
- 252-day
- +22.85% — 73rd percentile since 1972 (13309 obs) · from 24.51 USD on 2025-10-17
- Year to date
- +20.92% · from 24.90 USD on 2025-12-31
- Overnight vs intraday (20d)
- overnight +2.98% · intraday +4.69% (compounds to +7.81% total)
- Overnight vs intraday (60d)
- overnight +4.09% · intraday +17.25% (compounds to +22.05% total)
- Overnight vs intraday (252d)
- overnight +12.96% · intraday +8.75% (compounds to +22.85% total)
Market factor
- S&P 500 (52-week)
- beta +0.22 · correlation +0.14
- S&P 500 (26-week)
- beta +0.28 · correlation +0.14
- Nasdaq 100 (52-week)
- beta +0.02 · correlation +0.02
- Nasdaq 100 (26-week)
- beta -0.02 · correlation -0.02
- Health Care (XLV, 52-week)
- beta +0.42 · correlation +0.37
- Health Care (XLV, 26-week)
- beta +0.42 · correlation +0.36
- Health Care (XLV) — this stock's weight, as of 2026-06-30 (quarterly SEC filing)
- 2.4%
- 10Y TIPS real-yield change (52-week)
- correlation -0.44
- 10Y TIPS real-yield change (26-week)
- correlation -0.45
Key dates
- Next earnings
- 2026-11-03 (14 days)
- Next Fed decision (FOMC)
- 2026-10-28 (8 days)
- Next jobs report (BLS)
- 2026-11-06 (17 days)
- Next CPI (BLS)
- 2026-11-10 (21 days)
- Next quarterly index rebalance (S&P 500 & Nasdaq-100)
- 2026-12-18 (59 days) — effective the following trading day
- Next monthly options expiration
- 2026-11-20 (31 days)
- Last earnings reported
- 2026-08-04 (77 days ago)
- Earnings reaction (realised)
- ±1.60% median 1-day move · 0.03–6.09% range · last 12 reported
- Recent SEC filings
- 8-K 2026-08-04 (Items 2.02, 9.01) · 10-Q 2026-08-04 · 10-K 2026-02-26 · proxy 2026-03-12 (EDGAR)
- Last ex-dividend
- 2026-07-24, $0.43
Volatility by rate-era
- pre-crisis (to 2008)
- 1.88% (data from 1972-06-01)
- ZIRP (2009–2015)
- 1.35%
- tightening (2015–2018)
- 1.08%
- ZIRP (2019–2021)
- 1.76%
- tightening (2022–2023)
- 1.59%
- easing (2024– )
- 1.51%
Market backdrop: 10Y 5.15% (as of 2026-10-19) · VIX 17.31 (as of 2026-10-20) · dollar 121.40 (as of 2026-10-16) — Treasury curve, real yields, VIX and the dollar
Risk & context
- RSI: Overbought
- Volatility: Normal (changed)
- 52-week position: Near 52-week high
- Beta: Low
- Relative volume: Normal
- Earnings: 2026-11-03
What these badges mean
- RSI
- RSI(14) is 72.56. Below 30 oversold, 70 and above overbought; between them neither extreme: 30–45 neutral-low, 45–55 neutral, 55–70 neutral-high. A condition, not a direction.
- Volatility
- 20-day realised volatility at the 29th percentile of its own history since 1972. Higher = larger daily swings; a risk measure, not a direction.
- 52-week position
- Trading at 97.9% of the 52-week range. Position only — being near the high is not itself bullish or bearish.
- Beta
- 52-week beta to the S&P 500 is +0.22. Higher = amplifies market moves; a risk measure, not a direction.
- Relative volume
- Relative volume 1.14x its 20-day average, 72nd percentile since 1972. Participation behind the move; not a direction.
- Earnings
- Next scheduled earnings: 2026-11-03 (in 14 days).
Scoring method
- Short-term momentum
- Majority of three votes: the combined 5- and 10-day returns (one vote); MACD against its signal line; the histogram's change on the previous session. A tie reads Mixed.
- Medium-term trend
- Based on the majority sign of the medium-term return horizons.
- Moving averages
- Scored on price vs the 50- and 200-day trend averages.
- Relative performance
- Scored on the majority sign of relative return vs the S&P 500.
Relative performance
This stock’s return minus a benchmark’s over the same window (percentage points; positive = outperformed), at three adjustments: raw vs the index, beta-adjusted excess (isolating the stock-specific move) and vs its sector ETF.
Raw, vs market index
| Relative return | S&P 500 | Nasdaq 100 |
|---|---|---|
| 5-day | +7.32% | +9.62% |
| 10-day | +10.85% | +15.02% |
| 20-day | +8.48% | +11.80% |
| 60-day | +18.01% | +16.85% |
| 252-day | +7.11% | +4.02% |
Beta-adjusted excess
Stock return minus its beta times the index’s return (single-factor approximation, not a causal claim).
| Excess return | S&P 500 | Nasdaq 100 |
|---|---|---|
| 1-day | +2.21% | +2.28% |
| 5-day | +6.40% | +6.20% |
| 10-day | +9.79% | +9.60% |
| 20-day | +7.95% | +7.89% |
| 60-day | +21.16% | +21.95% |
| 252-day | +19.39% | +22.47% |
vs sector ETF (XLV · Health Care)
Return minus the SPDR sector ETF’s (“vs XLV”; positive = outpaced the sector), plus the ETF’s own return.
| Sector return | vs XLV | XLV own |
|---|---|---|
| 1-day | -0.10% | +2.37% |
| 5-day | +0.14% | +5.99% |
| 10-day | +1.87% | +7.62% |
| 20-day | +1.96% | +5.84% |
| 60-day | +12.00% | +10.05% |
| 252-day | -2.66% | +25.51% |
Compared with other stocks
Rank among covered stocks
This stock’s standing on each measure across the covered-stock universe (1 = highest) — a cross-sectional companion to the own-history percentiles above, computed from the same daily dataset. Ranks compare each stock’s current reading; the underlying own-history percentiles draw on histories of differing length (some reaching into coarser early-era pricing), so they are not strictly comparable instrument-to-instrument — read each alongside its own “since YYYY” basis in the table above.
| Measure | Rank |
|---|---|
| 20-day return | 10 of 48 stocks |
| RSI(14) | 5 of 48 stocks |
| 52-week position | 4 of 48 stocks |
| 20-day realised vol | 39 of 48 stocks |
| Relative volume | 9 of 48 stocks |
Of its 4 Health Care peers today: 4 up, 0 down · median +2.65% · Pfizer (PFE) +2.28% (-0.37 pp vs peer median).
Across the 48 covered stocks today: 29 advancing, 19 declining · 27/48 above their 20-day MA, 25/48 above 50-day, 28/48 above 200-day · median 20-day return -0.60%. Pfizer (PFE) is above its 20-, 50- and 200-day MAs (20-day return +8.41 pp vs the median stock).
Sector peers — Health Care
| Stock | Same-day | 20-day return | RSI percentile | 52-wk position | Next earnings |
|---|---|---|---|---|---|
| Pfizer (PFE) | +2.28% | +7.81% | 97th | 97.9% | 2026-11-03 · 14d |
| Johnson & Johnson (JNJ) | +2.19% | -3.65% | 38th | 77.5% | — |
| Eli Lilly (LLY) | +3.49% | +9.70% | 92nd | 94.6% | 2026-10-29 · 9d |
| UnitedHealth (UNH) | +3.04% | +12.42% | 94th | 79.4% | 2027-01-12 · 84d |
| AbbVie (ABBV) | +2.26% | +9.00% | 92nd | 97.7% | 2026-10-30 · 10d |
Each stock’s own latest readings for 2026-10-20, from the same daily dataset. 52-week position: 0% at the low, 100% at the high.
Full daily summary
At the 2026-10-20 close, Pfizer (PFE) traded at 97.9% of its 52-week range. At the 2026-10-20 close, Pfizer (PFE) had an RSI(14) of 72.56, in the 97th percentile of its history since 1972. Its 20-day return of +7.81% is in the 86th percentile of its history since 1972. RSI above 70 is conventionally termed overbought. The RSI(14) of Pfizer (PFE) last entered the overbought zone today (2026-10-20) and the oversold zone 118 days ago (2026-06-24). It is trading above its 20-, 50- and 200-day moving averages. At the 2026-10-20 close, the 20/50/200-day moving averages of Pfizer (PFE) were 28.54 / 28.08 / 26.61 USD, with price +5.52% / +7.21% / +13.15% against them. Ranked from highest to lowest, its moving averages are the 20-day, 50-day and 200-day. At the 2026-10-20 close, the 52-week range of Pfizer (PFE) was 23.62–30.25 USD; it closed 0.46% below the high (0.3× its typical daily range) and 27.48% above the low (11.6× its typical daily range). The high was set today (2026-10-20) and the low 106 days ago (2026-07-06). At the 2026-10-20 close, Pfizer (PFE) was 51.21% below its all-time intraday high of 61.71 USD, set 1765 days ago (2021-12-20). Its 20-day volatility is 1.189% daily, in the 29th percentile of its history since 1972. Its daily realised volatility is 1.392% over 5 days, 1.189% over 20 days, 1.239% over 60 days and 1.276% over 120 days. Annualised, these are 22.1%, 18.9%, 19.7% and 20.3% respectively. Its 14-day average true range (ATR) is 0.56 USD, 1.87% of price. It has returned +6.13% (95th percentile since 1972) over 5 days, +9.49% (96th) over 10 days, +7.81% (86th) over 20 days, +22.05% (96th) over 60 days, +14.66% (76th) over 120 days and +22.85% (73rd) over 252 days. Against the S&P 500, its weekly returns show a beta of +0.22 and a correlation of +0.14 over 52 weeks; over 26 weeks, a beta of +0.28 and a correlation of +0.14. Relative to the S&P 500, it has returned +7.32% (5-day), +10.85% (10-day), +8.48% (20-day), +18.01% (60-day) and +7.11% (252-day). Its weekly-return correlation with changes in the US 10-year TIPS real yield is -0.44 over 52 weeks and -0.45 over 26 weeks. Next earnings are scheduled for 2026-11-03.
Methodology
This page reports market statistics computed from daily closing data. It states figures and their historical context, and adds a Technical Assessment: a transparent, rules-based reading that puts those same statistics into plain language, including a factor sign tally — a count of how many scored factors read positive, negative or mixed, not a composite score or analyst rating. Every reading follows a fixed, published rule and traces back to the metrics on this page. It is informational and educational only — not investment advice, a price target, a forecast or a recommendation to buy or sell.
Full definitions for every metric on this page — how each is computed, over what window and on what basis — are on the methodology page.
Machine-readable: this page’s numbers and 252-session price history as JSON or the daily close and moving-average series as CSV — the figures above plus the series behind the chart, refreshed each session.
See where Pfizer (PFE) ranks among today’s most statistically unusual readings on the cross-asset market screener.
See what RSI extremes and other signals have historically been followed by for Pfizer (PFE) in its measured signal track record.